Biomarkers in the evaluation of cardiac involvement in systemic sclerosis
Systemic sclerosis is a multisystemic disease for which the heart can be affected leading to
cardiac complications and mortality. Up to 80% of patients with systemic sclerosis have …
cardiac complications and mortality. Up to 80% of patients with systemic sclerosis have …
Therapeutic strategies for primary heart involvement in systemic sclerosis
V Batani, L Dagna, G De Luca - Rheumatology and Immunology …, 2024 - degruyter.com
Primary heart involvement (pHI) is frequent in systemic sclerosis (SSc), even though often
underdiagnosed. SSc-pHI has been recently defined as cardiac abnormalities that are …
underdiagnosed. SSc-pHI has been recently defined as cardiac abnormalities that are …
[HTML][HTML] Anti-SRP Antibodies and Myocarditis in Systemic Sclerosis Overlap Syndrome with Immune-Mediated Necrotizing Myositis (IMNM)
C Alexandru, A Donisa, F Bobirca, AM Dascalu… - Medicina, 2024 - mdpi.com
Overlap syndrome of systemic sclerosis and idiopathic inflammatory myopathies is an
increasingly frequent entity, but the association with immune-mediated necrotizing myositis …
increasingly frequent entity, but the association with immune-mediated necrotizing myositis …